First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    DaVita Inc.

    DVA · 3 developments mapped · last assessed 2026-09-04

    Market Ontology has mapped 3 macro, policy, and market developments to DaVita Inc. since 2026-09-04. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for DVA yet, so no modelled value is shown. The DVA valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run DVA on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for DVA. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Main threat

      Fresenius Medical Care converts 227 US clinics to 5008X CAREsystem

      Increased competitive pressure from a major rival's technological advancement and potential for market share shifts if FMS's new system offers superior patient outcomes or cost efficiencies.

      · Moves future revenue growth rate for dialysis services, market share stability, need for competitive capital expenditures

    • Open question

      Fresenius Medical Reaches 10% U.S. Machine Base Conversion with 5008X System

      Competitive pressure from a key rival's technological advancement. While not directly impacted, FMS's improved offerings could make DVA's services comparatively less attractive or pressure DVA to invest more in its own technology.

      · Moves competitive landscape, future capital expenditure requirements, market share stability

    What changed, by assumption

    Future revenue growth rate for dialysis services
    • 2026-09-04Fresenius Medical Care converts 227 US clinics to 5008X CAREsystem
    Market share stability in the u.s. dialysis market
    • 2026-09-04Fresenius Medical Care Converts 227 US Clinics to 5008X Hemodiafiltration System
    Competitive landscape
    • 2026-09-04Fresenius Medical Reaches 10% U.S. Machine Base Conversion with 5008X System

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-04Fresenius Medical Care converts 227 US clinics to 5008X CAREsystemBearish3-12m0.40
    2026-09-04Fresenius Medical Care Converts 227 US Clinics to 5008X Hemodiafiltration SystemBearish3-12m0.40
    2026-09-04Fresenius Medical Reaches 10% U.S. Machine Base Conversion with 5008X Systemmixed3-12m0.40